Pharmacist Advanced Training Long-Acting Injectables | Microcredentials On-Demand 4 credit hours

This practical training prepares pharmacists to administer long-acting injectable medications in the pharmacy setting and support patients receiving injectable therapies as part of ongoing disease management. 

Designed as a microcredential program, this course awards a digital badge upon successful completion and focuses on the clinical, operational, and workflow considerations associated with pharmacy-based injectable services. 

The program explores best practices for the administration of long-acting injectables across a variety of therapeutic areas while emphasizing patient safety, adherence, and continuity of care. 

Topics covered include:

  • Overview of long-acting injectable therapies and their role in patient care  
  • Storage, handling, preparation, and administration requirements  
  • Injection techniques and administration considerations for various products  
  • Workflow integration and operational considerations for pharmacy practice  
  • Patient counseling, monitoring, and follow-up care  
  • Documentation and billing considerations related to injectable services  
  • Strategies to support medication adherence and continuity of therapy  
  • Safety considerations, adverse effect monitoring, and error prevention  

Pharmacists will also develop practical skills in evaluating injectable medication requirements, preparing products appropriately, counseling patients on treatment expectations, and implementing pharmacy-based administration services within practice workflow. 

This training is designed to help pharmacists expand clinical service offerings, improve patient access to injectable therapies, and support long-term treatment adherence and outcomes. 

Earn your microcredential and build confidence in providing pharmacy-based long-acting injectable services – enroll today.

Long-Acting Injectables - Pharmacist

Claim Your Badge

You will receive an email from Credly (our credential partner), after you complete the course, inviting you to claim your digital badge for Long-Acting Injectables - Pharmacist. This will allow you to easily share your achievement with colleagues, managers, and your professional network on LinkedIn and other platforms. When you receive the email, please click the button and create an account on Credly.com so that you can “accept” the badge.

Need help? Find a step-by-step tutorial video at this link.

Module 1

Upon successful completion of this module, pharmacists should be able to:
1. Describe the signs, symptoms, and diagnostic criteria for schizophrenia and bipolar disorder.
2. List the benefits and challenges associated with the use of long-acting injectable (LAI) antipsychotics.
3. Compare the FDA-approved LAI antipsychotics, including preparation and administration.
4. Discuss the role of the pharmacist in the administration of LAI antipsychotics in the pharmacy setting.
5. Formulate a strategy to transition a case-based patient from an oral antipsychotic to a LAI antipsychotic.

Module 2

Upon successful completion of this module, pharmacists should be able to:
1. Review the various types of injections that may be delivered in pharmacy practice.
2. Identify techniques and recommended practices for delivering injectable medications.
3. Assess the appropriate injection method based on patient factors, medication characteristics, and safety considerations.

Module 3

Upon successful completion of this module, pharmacists should be able to:
1. Discuss the opportunities and challenges of developing a LAI service.
2. Describe the key components and procedures necessary for implementing a LAI administration service.
3. Develop a policy, procedure, and plan for providing LAI administration services.
4. Recognize options to expand LAI administration through community partnerships.

Module 4

Upon successful completion of this module, pharmacists should be able to:
1. Identify the considerations for administering long-acting injectables (LAIs).
2. Describe common FDA-approved non-antipsychotic LAIs administered at the pharmacy.
3. Discuss monitoring and follow-up plan recommendations for each injection.
4. Develop a treatment plan to transition a case-based patient from an oral medication to an LAI non- antipsychotic.

Faculty

Elizabeth Skoy, PharmD

Disclosures:

Elizabeth Skoy has no relevant financial relationships with ineligible companies to disclose.

Katelynn Mayberry, PharmD

Disclosures:

Katelynn Mayberry has no relevant financial relationships with ineligible companies to disclose.

Lindsay McCoy, PharmD, BCPP

Disclosures:

Lindsay McCoy has no relevant financial relationships with ineligible companies to disclose.

Course Details